Bank of New York Mellon’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Bank of New York Mellon’s Portfolio YTEN Stock Details YTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1	Closed	-$30K	–	4341
2015 Q1	$30K	Hold	1	–	–	﹤0.01%	4171
2014 Q4	$20K	Hold	1	–	–	﹤0.01%	4209
2014 Q3	$45K	Hold	1	–	–	﹤0.01%	4149
2014 Q2	$43K	Hold	1	–	–	﹤0.01%	4086
2014 Q1	$63K	Hold	1	–	–	﹤0.01%	4055
2013 Q4	$61K	Hold	1	–	–	﹤0.01%	4087
2013 Q3	$61K	Hold	1	–	–	﹤0.01%	4028
2013 Q2	$69K	Buy	+1	New	+$96.7K	﹤0.01%	3994

Other funds holding YTEN

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCM

McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return

Bank of New York Mellon's YTEN Position: Q2 2015 in Review

Bank of New York Mellon sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2015, closing a stake of 1 share — an estimated $30K sold.

Bank of New York Mellon first reported a position in YTEN in Q2 2013 and held it in 8 quarters. The position peaked at $69K in Q2 2013. 11 funds tracked by Wall St. Rank hold YTEN as of Q2 2015.

Bank of New York Mellon reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
Bank of New York Mellon sold 1 Yield10 Bioscience, Inc. Common Stock share in Q2 2015, an estimated $30K.
Bank of New York Mellon first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
Bank of New York Mellon's Yield10 Bioscience, Inc. Common Stock position peaked at $69K in Q2 2013.
11 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2015.

Based on Bank of New York Mellon's 13F filing for Q2 2015, filed 6 Aug 2015.